------Dr Barry M Elliott -----------------------------

Dr Elliott was appointed as a member in April 2006. He has extensive experience over 25 years on the application of test methods and strategies for investigating the mutagenicity of chemicals and assessment of data. He has expertise in the use of structure activity relationships to assist in the assessment of genotoxicity and the interpretation of data, together with the integration of genotoxicity data with carcinogenicity data. He is now an independent consultant in genetic toxicology and related areas.

Declaration Of Interests

Personal Interest

Non-personal Interest

Company

Interest

Company

Interest

Syngenta

AstraZeneca

Elliott GT Ltd

Regulatory Science

Associates

Pension

Shareholder

Share Holder

Director

Associate

NONE